188 results on '"Lundgren, Torbjörn"'
Search Results
2. Time trends in preemptive kidney transplantation in Europe: an era registry study
3. Nephrology in Sweden
4. Outcome after total pancreatectomy with islet autotransplantation: A European single-center study.
5. Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
6. Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients
7. Outcome after total pancreatectomy with islet autotransplantation: A European single-center study
8. 245.2: Evaluation of Methods to Obtain Peripheral Blood Mononuclear Cells From Deceased Donors Adjacent to Organ Procurement for Tolerance-Induction Protocols
9. 241.2: A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation
10. International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study.
11. International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study
12. Contributors
13. Treating diabetes with islet transplantation: Lessons learnt from the Nordic network for clinical islet transplantation
14. Isoallopregnanolone Inhibits Estrus Cycle-Dependent Aggressive Behavior
15. Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand
16. INTRAABDOMINAL, PREPERITONEAL AND INTERSTITIAL HERNIOPLASTY OF INCISIONAL HERNIA AFTER KIDNEY TRANSPLANTATION IS SAFE AND EFFECTIVE EVEN WHEN THE ABDOMINAL WALL DEFECT IS LARGE
17. Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type
18. Trends in kidney transplantation rate across Europe: study from the ERA Registry
19. Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
20. Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation
21. Present State of Islet Transplantation for Type 1 Diabetes Patients
22. Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation Using Induction Treatment of the Non-Hematopoetic Erythropoietin Analogue Cibinetide in a Mouse Model
23. Ex-Vivo Generation of Alloantigen-Specific Immunomodulatory Cells: Elucidating the Mechanistical Synergy of Cell Components
24. A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation
25. On the Etiology of Type 1 Diabetes: A New Animal Model Signifying a Decisive Role for Bacteria Eliciting an Adverse Innate Immunity Response
26. Scoring of medial arterial calcification predicts cardiovascular events and mortality after kidney transplantation
27. Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation
28. Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden – a decade of follow‐up
29. US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?
30. Supplemental Material, sj-docx-1-cll-10.1177_09636897211039739 - Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation
31. A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation.
32. Chapter 48 - Treating diabetes with islet transplantation: Lessons learnt from the Nordic network for clinical islet transplantation
33. Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation
34. The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA‐EDTA Registry – a retrospective study
35. Clinical aspects and perspectives in islet xenotransplantation
36. SO042WHOLE GENOME SEQUENCING OF HUMAN KIDNEY PROGENITORS IDENTIFIES A MUTATION-PRONE CELL TYPE IN THE PROXIMAL TUBULE
37. Xenotransplantation – Clinical Activities and Regulatory Development
38. Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet Transplantation
39. Tissue Factor Produced by the Endocrine Cells of the Islets of Langerhans Is Associated With a Negative Outcome of Clinical Islet Transplantation
40. ABO Incompatible Kidney Transplantations Without Splenectomy, Using Antigen-Specific Immunoadsorption and Rituximab
41. Xenotransplantation – Clinical Activities and Regulatory Development
42. The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA‐EDTA Registry – a retrospective study.
43. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes.
44. Calcium
45. Renal volumetry with magnetic resonance imaging
46. Rare progerin-expressing preadipocytes and adipocytes contribute to tissue depletion over time
47. Evaluation of Perfluorohexyloctane/Polydimethylsiloxane for Pancreas Preservation for Clinical Islet Isolation and Transplantation
48. Implantation of Autologous Selected Renal Cells in Diabetic Chronic Kidney Disease Stages 3 and 4—Clinical Experience of a “First in Human” Study
49. Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation
50. A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted Islets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.